You can get treatment for pattern hair loss (androgenetic alopecia) online through Bidwell Health for a flat $45 visit fee, with no insurance required. A U.S.-licensed nurse practitioner reviews your intake and, if your pattern is consistent with AGA, sends a prescription — typically finasteride 1 mg, topical minoxidil 5%, or a combination — electronically to your pharmacy. Most patients have their medication in hand within two hours during business days.
Androgenetic alopecia (ICD-10 L64.9) — also called male-pattern or female-pattern hair loss — is the most common cause of hair loss in adults. According to the American Academy of Dermatology (AAD), it affects roughly 50 million men and 30 million women in the U.S. The mechanism involves the hormone dihydrotestosterone (DHT), which progressively miniaturizes susceptible hair follicles until they stop producing visible hair.
In men, the pattern is typically a receding hairline, thinning crown (vertex), or both. In women, it's usually diffuse thinning over the top of the scalp with preserved hairline. AAD guidelines support FDA-approved first-line therapy (finasteride for men, topical minoxidil for men and women) along with off-label adjuncts (oral minoxidil, dutasteride, spironolactone) for patients who don't respond. Starting treatment early matters — you can preserve hair you still have, but lost follicles don't come back.
Adults 18+ qualify for async hair loss treatment if the pattern is consistent with androgenetic alopecia — receding hairline, crown thinning, or widening central part, typically with a family history. Patchy loss, sudden diffuse shedding, scalp inflammation, and pregnancy or pregnancy plans within six months are excluded. Classic androgenetic alopecia patterns include:
You qualify for a Bidwell telehealth hair loss visit if you are:
AAD androgenetic alopecia resources support first-line treatment with finasteride (for male pattern) and topical minoxidil (for men and women). Oral minoxidil at low dose (1.25–2.5 mg daily) and dutasteride are off-label but evidence-supported alternatives for patients who need them. Visible results typically take 3–6 months of consistent use. In detail:
We do not prescribe spironolactone without labs (potassium, kidney function) and typically refer women needing spiro to a dermatologist for initial setup. We do not prescribe PRP or hair transplant coordination — those require in-person specialists.
Hair loss has many possible causes and each responds to different treatment. Androgenetic alopecia (pattern baldness), alopecia areata (autoimmune patchy loss), telogen effluvium (diffuse shedding after stress or illness), scarring alopecia, traction alopecia, and thyroid or iron-related shedding all present differently and need different management. Here's how they typically differ:
| Condition | Telltale feature | Primary approach |
|---|---|---|
| Androgenetic alopecia | Gradual patterned thinning (temples, crown, central part), family history | Finasteride, minoxidil, or combination — what we treat |
| Alopecia areata | Round or coin-shaped bald patches, often sudden; possibly nail pitting | Dermatology — intralesional steroids, topicals, JAK inhibitors |
| Telogen effluvium | Diffuse shedding, 2–4 months after illness, childbirth, major stress | Time — typically self-resolves in 6–9 months; address trigger |
| Scarring alopecia | Smooth, shiny bald patches with no visible follicles; inflammation, itching | Dermatology — urgent evaluation to halt progression |
| Traction alopecia | Hair loss along tight hairstyle or extension lines | Stop tension; regrowth possible early |
| Thyroid / nutritional / iron-related | Diffuse shedding with systemic symptoms | Labs + treat underlying cause |
Our intake asks the specific questions needed to distinguish these. If your answers suggest something other than AGA, we'll say so and refund the visit.
AAD-supported options for androgenetic alopecia: finasteride 1 mg daily (FDA-approved for men), topical minoxidil 5% (FDA-approved for men and women), oral minoxidil 1.25–2.5 mg daily (off-label, evidence-supported), or dutasteride 0.5 mg daily (off-label). Your provider picks based on pattern severity, tolerance of systemic vs. topical, and pregnancy status.
| Medication | How it works | Status | Key notes | Cash price (monthly) |
|---|---|---|---|---|
| Finasteride 1 mg oral daily | 5-alpha-reductase inhibitor — blocks DHT | FDA-approved for male AGA | Results in 3–6 months; contraindicated in pregnancy | $10–30 |
| Topical minoxidil 5% | Vasodilator at the hair follicle — extends growth phase | FDA-approved for men and women | Initial shed at weeks 2–8 is normal | $25–40 |
| Oral minoxidil 1.25–2.5 mg daily | Same mechanism as topical but systemic | Off-label; AAD-referenced | Can cause facial hair growth, ankle edema; monitor cardiovascular status | $15–40 |
| Dutasteride 0.5 mg daily | More potent 5-alpha-reductase inhibitor | Off-label; FDA-approved for BPH | For patients whose AGA progresses on finasteride | $20–60 |
| Factor | Bidwell Health | Dermatology clinic |
|---|---|---|
| Visit cost | $45 flat (medication $10–60 / month at your pharmacy) | $150–400 for first derm visit without insurance |
| Wait time | Under 2 hours, same-day review | Typically weeks to months for new appointments |
| Scope | Pattern hair loss (AGA) in adults meeting criteria | All hair loss types — needed for non-AGA diagnoses |
| Insurance required | No | Often required, or high cash price |
| Prescription delivery | Electronic to any pharmacy you choose | Paper or e-prescription |
| Follow-up | Secure messaging inside the portal | Schedule a new visit |
For men with uncomplicated androgenetic alopecia and no contraindications, our nurse practitioners typically offer either topical minoxidil 5% alone (for patients who prefer topical therapy or want to avoid systemic medication) or the combination of oral finasteride 1 mg daily plus topical minoxidil 5% (for patients wanting the strongest evidence-based approach). We set expectations clearly: visible results take 3 to 6 months, treatment must be continued indefinitely to maintain gains, and an initial minoxidil shedding phase is normal. For women — outside pregnancy and breastfeeding — we typically start with topical minoxidil 5%. Low-dose oral minoxidil and dutasteride are off-label options we discuss when first-line treatments haven't been adequate. We refer out for alopecia areata, scarring alopecia, suspected thyroid or iron deficiency, and any pattern that doesn't fit AGA.
Bidwell Health's nurse practitioners hold active, autonomous-practice licensure in 12 states — Arizona, Colorado, Connecticut, Florida, Iowa, Maryland, Montana, New Mexico, New York, Utah, Virginia, and Washington. State-by-state licenses are publicly verifiable through each state's board of nursing. Select your state:
Async telehealth is appropriate for uncomplicated androgenetic alopecia in adults who fit the pattern. Several situations fall outside async scope and need a dermatologist — patchy or coin-shaped bald spots, scarring alopecia, scalp inflammation or infection, sudden diffuse shedding, or pregnancy plans within six months while considering finasteride. Please see a dermatologist instead of (or in addition to) a telehealth visit if:
Yes, for androgenetic alopecia (male-pattern and female-pattern hair loss) in adults with the classic pattern — gradual thinning at the temples, crown, or central part, typically with a family history. AAD clinical resources support first-line treatment with finasteride, topical minoxidil, or combination therapy. Alopecia areata, scarring alopecia, sudden diffuse shedding (telogen effluvium), pregnancy, and pregnancy plans within six months are excluded.
Most intakes are reviewed by a licensed nurse practitioner within two hours during business days. Once the provider approves, your prescription is e-prescribed to your chosen pharmacy and is typically ready for pickup within another hour. Weekend and holiday turnaround can run longer — we tell you before you pay if review times are stretching.
$45 flat for the visit. Medication billed separately at your pharmacy — finasteride 1 mg runs $10–30/month, topical minoxidil 5% $25–40/month, low-dose oral minoxidil (off-label) $15–40/month, dutasteride (off-label) $20–60/month. No insurance required, no subscription.
Every intake is reviewed by a U.S.-licensed nurse practitioner. Our clinicians are AANP board-certified Family Nurse Practitioners credentialed through your state's board of nursing, operating under autonomous-practice authority. No rules engine, no auto-approval — a human reads the intake line by line before anything is prescribed.
We don't treat hair loss when any of the following apply: patchy or coin-shaped bald spots (alopecia areata), scarring alopecia (smooth shiny patches or inflammation), sudden diffuse shedding after illness or childbirth (telogen effluvium), scalp inflammation or fungal infection, pregnancy or pregnancy plans within six months (finasteride and dutasteride are contraindicated), or active suicidal ideation (finasteride has mood effects in a small subset). Those need dermatology or primary-care evaluation.
If your intake surfaces any contraindication — a red-flag symptom, a condition we don't treat async, an unclear differential, or a medication interaction — we tell you, refund your $45 automatically, and direct you to the appropriate in-person option. You don't pay for care that shouldn't be delivered through async telehealth.
No. Bidwell Health is cash-pay only. The $45 flat fee covers the clinical review and, if appropriate, the prescription. You can pay with HSA/FSA funds. Because we don't bill insurance, your visit doesn't appear on your explanation of benefits or family insurance claims — which many patients prefer for privacy reasons.
Yes — for typical androgenetic alopecia with photos and a clear history, telehealth works. Our intake screens for red flags that need a dermatologist.
Most men get oral finasteride 1mg daily with or without topical or oral minoxidil. Women are usually prescribed topical or low-dose oral minoxidil. Dutasteride is an off-label option for men who don't respond to finasteride.
Most people shed a little more in the first 2–8 weeks (normal), see stabilization at 3–6 months, and maximum benefit at 12 months. Give any regimen at least 6 months before switching.
Not women of reproductive age — it causes birth defects in male fetuses. Postmenopausal women may use it off-label with dermatology oversight. We typically prescribe topical or low-dose oral minoxidil to women instead.
Most men have none. A small minority (under 4% in trials) report decreased libido, ED, or ejaculatory changes; these usually resolve on stopping. Post-finasteride syndrome (persistent symptoms) is rare but reported. Our intake reviews the risk-benefit trade-off with you.
Topical is FDA-approved and well-studied but can be messy and requires consistent daily application. Oral is off-label, easier, and often as effective or more so per recent JAAD research, but can cause extra facial hair, lightheadedness, or ankle swelling. Your NP will help choose based on your preferences.
No. Androgenetic alopecia is chronic and progressive. Stopping means gains reverse in 6–12 months. Most patients continue treatment indefinitely.
Yes. Finasteride plus minoxidil (topical or oral) is a common, evidence-backed combination for men. Sometimes dutasteride replaces finasteride for stronger effect. Your NP will build a plan based on your photos, goals, and preferences.
Generic finasteride runs $10–$25/month with GoodRx. Topical minoxidil 5% is $20–$40 for a 3-month supply OTC. Oral minoxidil is $15–$40/month. Dutasteride is $25–$60/month. Compared to subscription telehealth at $30–$60/month plus rebranded meds, pay-per-visit is usually cheaper over time.
No — hair loss medications are considered cosmetic by nearly all insurance plans, so insurance wouldn't cover them anyway. Bidwell is cash-pay: $45 flat for the visit, plus whatever the pharmacy charges for the medication (use GoodRx).
The shedding phase is where patients quit. The number-one reason men abandon finasteride or minoxidil before it works is the 6–8 week shedding phase — where old hairs release to make room for new growth, looking to the patient like the medication is actively causing hair loss. It's a recognized transition, not a failure. Telling patients about it upfront — and showing baseline scalp photos to compare against at month 6 — is the single biggest adherence intervention. Patients who know to expect the shed almost never stop; patients who don't almost always do.
Telogen effluvium masquerades as male-pattern loss. Diffuse shedding 2–4 months after a major stressor (illness, surgery, childbirth, crash diet, COVID infection) is telogen effluvium — it's self-limited and typically resolves in 6–9 months without any specific treatment. Starting finasteride in that context doesn't help and wastes three months of trial. Our intake specifically asks about recent illness, stress, or dietary change in the past 6 months to catch this pattern and route it to watchful waiting instead.
Women with pattern hair loss need different workup. Female pattern hair loss often coexists with iron deficiency, thyroid dysfunction, or PCOS. Before topical minoxidil — which is FDA-approved for women — a baseline lab check (ferritin, TSH, free testosterone, DHEA-S) rules out reversible drivers. Finasteride and dutasteride are contraindicated in women of childbearing potential and aren't a starting point. We currently focus on male pattern and refer women to dermatology or primary care for the lab workup that typically precedes treatment.